OCS / Mitie — £3.1bn M&A Transaction Analysis

Executive summary

OCS has agreed to acquire Mitie for 218.5p in cash per share. Including Mitie's permitted FY26 final dividend of up to 3.1p, shareholders can receive total value of up to 221.6p per share, implying a fully diluted equity value of approximately £3.1bn. The headline value represents a 46.8% premium to Mitie's 151.0p unaffected closing price on 20 July 2026.

The combination has clear industrial logic: a larger UK-headquartered facilities-management platform with broader service capability, sector exposure and geographic reach. The fit is strongest in complex outsourced environments such as government, defence, healthcare, infrastructure and large commercial estates. The central question is whether those strategic benefits are sufficient to justify a substantial control premium and the financing burden required to execute the transaction.

Transaction overview & offer premium

Mitie shareholders are offered 218.5p in cash and may retain the FY26 final dividend of up to 3.1p per share, giving total headline value of 221.6p. The 218.5p cash price represents a 44.7% premium to the unaffected close, while the headline value raises that premium to 46.8%. The premium remains meaningful against the three-month and six-month VWAPs and even against Mitie's prior all-time high.

The acquisition is being implemented through a court-sanctioned scheme of arrangement. The scheme document was published on 13 August 2026, shareholder meetings are scheduled for 16 September 2026 and completion is expected in Q1 2027, subject to shareholder, court and regulatory approvals.

Strategic rationale & target quality

The combination creates a significantly larger facilities-management platform with broader geographic reach, sector exposure and technical capability. Greater scale can improve procurement, bidding capability, technology investment and the ability to service large multi-site contracts. OCS can also gain greater exposure across government, defence, healthcare, infrastructure and other mission-critical environments.

Mitie entered the transaction from a position of strength rather than distress. FY26 revenue was £5.619bn, operating profit before Other items was £264m and free cash flow was £162m, alongside a £16.3bn order book. The buyer is therefore paying for quality and strategic scarcity rather than relying on a simple turnaround thesis.

Financing & capital structure

OCS is backed by Clayton, Dubilier & Rice. Public commitment documentation provides for a £1.5bn bridge facility, £2.5bn term loan B and £800m revolving credit facility, alongside sponsor support from CD&R. The debt package provides certainty of funds but makes post-close cash conversion and deleveraging central to the investment case.

The financing package is larger than the Mitie purchase price because the transaction financing also supports refinancing requirements within the OCS capital structure. The headline facility amounts should therefore not be interpreted as acquisition debt drawn solely to fund the £3.1bn equity purchase.

Merger economics

OCS has not publicly disclosed a quantified synergy target. The accompanying model therefore tests illustrative £50m, £100m and £150m annual synergy cases rather than presenting them as company guidance. The strongest potential buckets are duplicated corporate overhead, procurement, technology and platform consolidation, with cross-selling treated more cautiously because revenue synergies are harder to underwrite.

The base analytical case uses £100m of illustrative annual synergies to test how execution could affect leverage and value creation. The key requirement is that the enlarged group converts scale into EBITDA and free cash flow quickly enough to reduce financing risk rather than relying on exit-multiple support.

Key risks

The principal risks are integration across two large facilities-management organisations, customer and contract disruption, the size of the takeover premium, leverage and refinancing risk, and the remaining shareholder, court and regulatory conditions. At a 46.8% headline premium, the price leaves less room for execution error.

Final judgement

The transaction is strategically credible but financially demanding. The businesses fit well; the harder question is whether the value of that fit exceeds the price and financing burden. My assessment is that the premium is defensible, but not cheap. The transaction works best if OCS realises meaningful cost efficiencies, protects Mitie's customer franchise and uses the combined group's cash generation to reduce leverage quickly. If those conditions are met, the enlarged group can justify the strategic premium. If they are not, the acquisition price leaves limited downside protection.

Sources & methodology

• Mitie / OCS Rule 2.7 offer announcement.
• Mitie FY26 annual report.
• OCS reports and accounts.
• Debt and equity commitment letters linked in the model source notes.

Synergy cases are illustrative scenarios, not company guidance.

Downloads

For the full analysis, download the formatted PDF report. The accompanying Excel model includes the deal summary, financing structure, operating case, leverage and deleveraging analysis, illustrative sponsor returns, sensitivities and source notes.

Disclosure: Independent academic work for educational purposes. This is not investment advice or a recommendation on the transaction.